Ellington Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ellington Management Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-13,900	Closed	-$119K	–	642
2019 Q3	$119K	Buy	+13,900	New	+$135K	0.02%	549
2016 Q1	–	Sell	-16,358	Closed	-$159K	–	595
2015 Q4	$159K	Buy	+16,358	New	+$158K	0.06%	501
2015 Q2	–	Sell	-16,119	Closed	-$216K	–	774
2015 Q1	$216K	Buy	+16,119	New	+$211K	0.04%	576

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellington Management Group's IRWD Position: Q4 2019 in Review

Ellington Management Group sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2019, closing a stake of 13,900 shares — an estimated $119K sold.

Ellington Management Group first reported a position in IRWD in Q1 2015 and held it in 3 quarters. The position peaked at $216K in Q1 2015. 195 funds tracked by Wall St. Rank hold IRWD as of Q4 2019.

Ellington Management Group reported no remaining Ironwood Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Ellington Management Group sold 13,900 Ironwood Pharmaceuticals shares in Q4 2019, an estimated $119K.
Ellington Management Group first reported a position in Ironwood Pharmaceuticals in Q1 2015 and held it in 3 quarters.
Ellington Management Group's Ironwood Pharmaceuticals position peaked at $216K in Q1 2015.
195 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.